Agilent Technologies Inc vs Health Care Select Sector SPDR Fund — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.22B), while Health Care Select Sector SPDR Fund trades at $167.58. The key difference: Agilent Technologies Inc pays a 0.68% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | XLV | |
|---|---|---|
Market Cap | $42.22B | — |
Sector | Health | — |
52-Week High | $157.20 | $168.44 |
52-Week Low | $110.24 | $131.16 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | — |
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →